Surgical Innovations Group plc (AIM:SUN)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 6.53M |
| Revenue (ttm) | 11.95M |
| Net Income (ttm) | -1.94M |
| Shares Out | 932.82M |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | 0.22 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 903,601 |
| Average Volume | 583,972 |
| Open | 0.6600 |
| Previous Close | 0.7000 |
| Day's Range | 0.6600 - 0.7000 |
| 52-Week Range | 0.4210 - 0.7700 |
| Beta | 0.29 |
| RSI | 94.78 |
| Earnings Date | Sep 10, 2025 |
About Accolade
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It offers YelloPort Elite port access systems; YelloPort + Resposable port access systems; LogiCut, a disposable laparoscopic scissors; Logic, a reusable l... [Read more]
Financial Performance
In 2024, AIM:SUN's revenue was 11.95 million, a decrease of -0.57% compared to the previous year's 12.01 million. Losses were -1.94 million, 281.7% more than in 2023.
Financial StatementsNews
AIM Market Roundup: Gelion, Surgical Innovations, Deltex Medical
Gelion, Surgical Innovations, Deltex Medical, The Revel Collective, Cleantech Lithium are today's biggest risers and fallers on London's AIM market